VKH
ANIK icon

Virtu KCG Holdings’s Anika Therapeutics ANIK Stock Holding History

Virtu KCG Holdings’s Portfolio ANIK Stock Details ANIK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-4,391
Closed -$236K – 3040
2016
Q2 		$236K Sell
4,391
-2,825
-39% -$133K ﹤0.01% 2143
2016
Q1 		$323K Sell
7,216
-1,266
-15% -$51.4K 0.01% 1624
2015
Q4 		$324K Buy
+8,482
New +$324K 0.01% 2050
2014
Q4 		– Sell
-6,797
Closed -$249K – 3716
2014
Q3 		$249K Sell
6,797
-1,772
-21% -$76.6K ﹤0.01% 2608
2014
Q2 		$397K Buy
+8,569
New +$381K 0.01% 2212
2014
Q1 		– Sell
-8,763
Closed -$334K – 3494
2013
Q4 		$334K Buy
+8,763
New +$270K ﹤0.01% 2445

Other funds holding ANIK

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
TSW
Thompson Siegel & Walmsley Richmond, Virginia $5.57B AUM 9.46% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
AAM
AMI Asset Management Los Angeles, California $1.74B AUM 26.89% 1-Year Est. Return

Virtu KCG Holdings's ANIK Position: Q3 2016 in Review

Virtu KCG Holdings sold out of Anika Therapeutics (ANIK) in Q3 2016, closing a stake of 4,391 shares — an estimated $236K sold.

Virtu KCG Holdings first reported a position in ANIK in Q4 2013 and held it in 6 quarters. The position peaked at $397K in Q2 2014. 163 funds tracked by Wall St. Rank hold ANIK as of Q3 2016.

  • Virtu KCG Holdings reported no remaining Anika Therapeutics position as of Q3 2016 after selling out during the quarter.
  • Virtu KCG Holdings sold 4,391 Anika Therapeutics shares in Q3 2016, an estimated $236K.
  • Virtu KCG Holdings first reported a position in Anika Therapeutics in Q4 2013 and held it in 6 quarters.
  • Virtu KCG Holdings's Anika Therapeutics position peaked at $397K in Q2 2014.
  • 163 funds tracked by Wall St. Rank held Anika Therapeutics as of Q3 2016.

Based on Virtu KCG Holdings's 13F filing for Q3 2016, filed 10 Nov 2016.